Heritage (HRTG) Form 144: Insider Plans $332K Sale on NYSE

Rhea-AI Filing Summary

Heritage Insurance Holdings (HRTG) insiders filed a Form 144 proposing the sale of 13,197 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $332,300.46. The proposed sale is scheduled for 10/01/2025 on the NYSE. The shares were acquired as restricted stock units on 11/30/2017. The filing reports total shares outstanding of 31,017,570, and separately discloses 10b5-1 sales for Kirk Lusk of 20,000 shares on 09/12/2025 generating $483,374.00 in gross proceeds. The notice includes the standard insider representation about absence of undisclosed material information and references reliance on a trading plan where applicable; no plan adoption date or signature details are provided in the content.

Positive

• Disclosure compliance: Form 144 provides required details about the proposed sale, broker, and acquisition history.
• Shares acquired as RSUs: The securities originated from restricted stock units dated 11/30/2017, indicating compensation vesting rather than open-market purchases.
• Use of 10b5-1 plan: The filing references 10b5-1 sales, which can indicate pre-planned, rule-compliant insider selling.

Negative

• Insider selling: Proposed sale of 13,197 shares and recent 10b5-1 sale of 20,000 shares show insider monetization of HRTG stock.
• Missing plan/signature details in excerpt: The provided content does not include the trading-plan adoption date or a visible signature block to confirm execution of representations.

Insights

Financial Analyst

TL;DR: Insider intends to sell a small block of HRTG shares; disclosed 10b5-1 sales occurred recently, suggesting planned liquidity, not a large dilution event.

The proposed sale of 13,197 shares valued at $332,300 is small relative to 31.0 million shares outstanding (approximately 0.043%). The filing shows the shares originated from restricted stock units granted on 11/30/2017, indicating these are vested compensation shares being monetized. A prior 10b5-1 sale of 20,000 shares on 09/12/2025 produced $483,374, confirming recent insider selling activity. From a financial-materiality standpoint, these transactions are routine insider liquidity events and are unlikely to materially affect company valuation or share float absent additional undisclosed sales.

Corporate Governance Expert

TL;DR: Filing shows compliance with Rule 144 and disclosure of 10b5-1 sales; documentation lacks certain plan adoption details in the provided text.

The Form 144 reports required elements: class of security, broker, amount, market value, and acquisition details (Restricted Stock Units dated 11/30/2017). The filing also discloses a 10b5-1 sale by Kirk Lusk on 09/12/2025. However, the content does not include a stated plan adoption date or a visible signature block in the provided excerpt. For governance review, confirmation of the trading-plan adoption date and the filer’s signature would complete compliance documentation; the absence of those details in the text should be confirmed against the full filing record.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	13197	332300.46	31017570	10/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/30/2017	Restricted Stock Units	Issuer			13197	11/30/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for KIRK LUSK 1401 N. Westshore Blvd Tampa FL 33607	Common	09/12/2025	20000	483374.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares of HRTG are proposed for sale in this Form 144?

The filing proposes sale of 13,197 common shares of Heritage Insurance Holdings (HRTG).

When and where is the proposed sale scheduled?

The proposed sale is scheduled for 10/01/2025 on the NYSE through Morgan Stanley Smith Barney LLC.

What is the aggregate market value of the proposed 13,197-share sale?

The aggregate market value reported is $332,300.46.

How were the shares being sold originally acquired?

The shares were acquired as Restricted Stock Units on 11/30/2017.

Has the filer recently sold other HRTG shares?

Yes; the filing discloses 10b5-1 sales for Kirk Lusk of 20,000 shares on 09/12/2025 for gross proceeds of $483,374.00.

How significant is the proposed sale relative to shares outstanding?

The filing reports 31,017,570 shares outstanding; the 13,197-share block represents approximately 0.043% of outstanding shares.